PDC line Pharma SA
Dissolution volontaire – liquidation 22.4 FTEPDC line Pharma reported total assets of €3.76m at the end of the 2024 financial year (annual accounts filed with the NBB on 26 Aug 2025), with 22.4 full-time equivalents.
The score of PDC line Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Total assets -86 % Headcount (avg FTE) +58 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
PDC line Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 18 Jun 2023
- Year ended 31 Dec 2021filed on 07 Jun 2022
- Year ended 31 Dec 2020filed on 23 Jun 2021
PDC line Pharma's financial analysis
- Solvency-207.5%sector median: 57.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of PDC line Pharma
PDC line Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0657.842.221
- VAT number
- BE0657842221
- Peppol
- Registered · 0208:0657842221 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 30 Jun 2016
- Registered office
- 4000 Liège
- Size
- Small · 22.4 FTE
- Latest accounts
- 2024 · filed on 26 Aug 2025
- Activity
- Research and experimental development on biotechnology (NACE 72101)
PDC line Pharma (SA) has been based in Liège since 2016, active in: research and experimental development on biotechnology. For 2024, it reports a net loss of €11.0m and equity of −€7.80m; its revenue is not published. With 22.4 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at -207.5%, below the median of its sector (57.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to PDC line Pharma
Companies in the same business, of comparable size and area, outside its group.
- ExeVir Bio Research and experimental development on natural sciences and engineering Ghent · balance sheet €3.76m
- Genflow Biosciences Research and experimental development on natural sciences and engineering Charleroi · balance sheet €3.74m
- Tanai Therapeutics Research and experimental development on natural sciences and engineering Ghent · balance sheet €3.87m
- XomeXBio Research and experimental development on natural sciences and engineering Charleroi · balance sheet €3.50m
- Wishbone Research and experimental development on natural sciences and engineering Flémalle · balance sheet €3.39m
- Ipratech Research and experimental development on natural sciences and engineering Charleroi · balance sheet €4.29m
- Bio-Sourcing Research and experimental development on natural sciences and engineering Liège · balance sheet €6.59m
- Amyl Therapeutics Research and experimental development on natural sciences and engineering Liège · balance sheet €7.02m
Frequently asked questions about PDC line Pharma
What is the revenue of PDC line Pharma?
PDC line Pharma files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of PDC line Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0657842221 for PDC line Pharma, if the company is VAT-registered. Its company number (CBE) is 0657.842.221.
Where is the registered office of PDC line Pharma?
According to the CBE register, the registered office of PDC line Pharma is in 4000 Liège.
What is the equity of PDC line Pharma?
At the close of the 2024 financial year, the equity of PDC line Pharma amounts to -7,801,066 €, a solvency of -207.5% of total assets.
How many people work at PDC line Pharma?
22.4 full-time equivalents on average according to the 2024 social balance sheet.
Who manages PDC line Pharma?
The register lists 15 active mandates at PDC line Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of PDC line Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →